Epicardial ablation successfully terminated recurrent ventricular tachycardia and prevented recurrence for at least two years in a patient with ischemic cardiomyopathy.
Case Report (n=1)
No
Ischemic cardiomyopathy with ventricular tachycardia (n=1)
Epicardial ablation vs Endocardial ablation
Ventricular tachycardia recurrence
In ischemic cardiomyopathy, endocardial reentry has traditionally been the mechanistic paradigm for understanding ventricular tachycardia (VT). However, recognition is growing that epicardial myocardium is a critical component for VT substrate, even in patients with ischemic cardiomyopathy. In this report, we present a novel case of a three-dimensional VT reentry involving epicardial components and an endocardial exit.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yasuhito Kotake
C. Nalliah
Electrophysiology
Timothy Campbell
The University of Sydney
Journal of Innovations in Cardiac Rhythm Management
The University of Sydney
Westmead Hospital
Westmead Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Kotake et al. (Thu,) conducted a case report in Ischemic cardiomyopathy with ventricular tachycardia (n=1). Epicardial ablation vs. Endocardial ablation was evaluated on Ventricular tachycardia recurrence. Epicardial ablation successfully terminated recurrent ventricular tachycardia and prevented recurrence for at least two years in a patient with ischemic cardiomyopathy.
synapsesocial.com/papers/6a1545575347fbb1739f82af — DOI: https://doi.org/10.19102/icrm.2021.120402